| scholarly article | Q13442814 |
| P2093 | author name string | Hao Wang | |
| Armando Durazo | |||
| Lily Wu | |||
| Hsian-Rong Tseng | |||
| Yung-Ya Lin | |||
| Kuan-Ju Chen | |||
| Mitch A Garcia | |||
| Lian-Pin Hwang | |||
| Stephanie M Wolahan | |||
| Chao-Hsiung Hsu | |||
| Hsing-Wei Chang | |||
| Ziyue K Jiang | |||
| P2860 | cites work | Dendrimeric Gd(III) complex of a monophosphinated DOTA analogue: optimizing relaxivity by reducing internal motion. | Q46475133 |
| Enhanced tumor MR imaging with gadolinium-loaded polychelating polymer-containing tumor-targeted liposomes | Q57186552 | ||
| Supramolecular aggregates of amphiphilic gadolinium complexes as blood pool MRI/MRA contrast agents: physicochemical characterization | Q57187486 | ||
| Hybrid silica nanoparticles for multimodal imaging | Q80114576 | ||
| The clinical use of structural MRI in Alzheimer disease | Q24609648 | ||
| Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications | Q28212229 | ||
| Porous Polymersomes with Encapsulated Gd-labeled Dendrimers as Highly Efficient MRI Contrast Agents. | Q30584790 | ||
| Synthesis, characterization, and relaxivity of two linear Gd(DTPA)-polymer conjugates | Q30649084 | ||
| PAMAM dendrimeric conjugates with a Gd-DOTA phosphinate derivative and their adducts with polyaminoacids: the interplay of global motion, internal rotation, and fast water exchange | Q31049014 | ||
| A polymeric micelle MRI contrast agent with changeable relaxivity | Q31051836 | ||
| Non-covalent conjugates between cationic polyamino acids and GdIII chelates: a route for seeking accumulation of MRI-contrast agents at tumor targeting sites | Q33180963 | ||
| Nanoassembled capsules as delivery vehicles for large payloads of high relaxivity Gd3+ agents. | Q33509117 | ||
| A small library of DNA-encapsulated supramolecular nanoparticles for targeted gene delivery | Q33536471 | ||
| Gadolinium-conjugated dendrimer nanoclusters as a tumor-targeted T1 magnetic resonance imaging contrast agent | Q33822955 | ||
| The future of cancer imaging | Q34980546 | ||
| Clinical applications of cardiovascular magnetic resonance imaging | Q35062046 | ||
| Nano-sized MRI contrast agents with dendrimer cores | Q36313785 | ||
| Lymphangiogenesis in development and human disease | Q36342355 | ||
| Liposomal Gd-DTPA: preparation and characterization of relaxivity | Q36418133 | ||
| Imaging of the lymphatic system: new horizons | Q36693579 | ||
| Synthesis, characterization, and biological evaluation of integrin alphavbeta3-targeted PAMAM dendrimers. | Q36952077 | ||
| Nanoparticles in sentinel lymph node mapping. | Q37668388 | ||
| Photothermal effects of supramolecularly assembled gold nanoparticles for the targeted treatment of cancer cells | Q39714970 | ||
| A supramolecular approach for preparation of size-controlled nanoparticles | Q41332964 | ||
| Surface modification and functionalization of nanoscale metal-organic frameworks for controlled release and luminescence sensing | Q43014777 | ||
| Liposomes as carriers of amphiphilic gadolinium chelates: the effect of membrane composition on incorporation efficacy and in vitro relaxivity | Q43919780 | ||
| P433 | issue | 8 | |
| P921 | main subject | gadolinium | Q1832 |
| contrast agent | Q6849688 | ||
| nanoparticle | Q61231 | ||
| P1104 | number of pages | 6 | |
| P304 | page(s) | 2160-2165 | |
| P577 | publication date | 2010-12-16 | |
| P1433 | published in | Biomaterials | Q15751139 |
| P1476 | title | A small MRI contrast agent library of gadolinium(III)-encapsulated supramolecular nanoparticles for improved relaxivity and sensitivity | |
| P478 | volume | 32 |
| Q41572844 | A High-Throughput Platform for Formulating and Screening Multifunctional Nanoparticles Capable of Simultaneous Delivery of Genes and Transcription Factors |
| Q37453997 | A Microfluidic Platform to design crosslinked Hyaluronic Acid Nanoparticles (cHANPs) for enhanced MRI |
| Q37663672 | Bioabsorbable stent quo vadis: a case for nano-theranostics |
| Q38245165 | Bioapplications of hyperbranched polymers |
| Q36094353 | Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity |
| Q41572818 | Cross-Linked Fluorescent Supramolecular Nanoparticles as Finite Tattoo Pigments with Controllable Intradermal Retention Times |
| Q34932130 | Delivery of intact transcription factor by using self-assembled supramolecular nanoparticles |
| Q60930279 | Dendrimer- and copolymer-based nanoparticles for magnetic resonance cancer theranostics |
| Q95642955 | Dual Supramolecular Nanoparticle Vectors Enable CRISPR/Cas9-Mediated Knockin of Retinoschisin 1 Gene-A Potential Nonviral Therapeutic Solution for X-Linked Juvenile Retinoschisis |
| Q46749921 | Effective heating of magnetic nanoparticle aggregates for in vivo nano-theranostic hyperthermia |
| Q38267889 | Functional supramolecular polymers for biomedical applications |
| Q39062309 | Gadolinium oxysulfide nanoparticles as multimodal imaging agents for T2-weighted MR, X-ray tomography and photoluminescence |
| Q42379549 | Gadolinium-Loaded Viral Capsids as Magnetic Resonance Imaging Contrast Agents |
| Q38642313 | Gd3+-1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic-2-hydroxypropyl-β-cyclodextrin/Pluronic Polyrotaxane as a Long Circulating High Relaxivity MRI Contrast Agent. |
| Q90221132 | Glucosamine Conjugated Gadolinium (III) Oxide Nanoparticles as a Novel Targeted Contrast Agent for Cancer Diagnosis in MRI |
| Q38139328 | Host-guest supramolecular nanosystems for cancer diagnostics and therapeutics |
| Q38840049 | In vitro study of novel gadolinium-loaded liposomes guided by GBI-10 aptamer for promising tumor targeting and tumor diagnosis by magnetic resonance imaging |
| Q37664853 | Mannose-coated gadolinium liposomes for improved magnetic resonance imaging in acute pancreatitis |
| Q33715974 | Molecular recognition enables nanosubstrate-mediated delivery of gene-encapsulated nanoparticles with high efficiency |
| Q55329146 | Nano-therapeutic cancer immunotherapy using hyperthermia-induced heat shock proteins: insights from mathematical modeling. |
| Q26824262 | Nanoparticle-based systems for T(1)-weighted magnetic resonance imaging contrast agents |
| Q37114971 | On-demand drug release system for in vivo cancer treatment through self-assembled magnetic nanoparticles |
| Q47787964 | PEGylated crosslinked hyaluronic acid nanoparticles designed through a microfluidic platform for nanomedicine |
| Q48141131 | Positive variation of the MRI signal via intramolecular inclusion complexation of a C-2 functionalized β-cyclodextrin. |
| Q28829134 | Pretargeted Positron Emission Tomography Imaging That Employs Supramolecular Nanoparticles with in Vivo Bioorthogonal Chemistry |
| Q38204933 | Recent advances in biocompatible nanocarriers for delivery of chemotherapeutic cargoes towards cancer therapy |
| Q47366310 | Self-Assembled Nanomicelles as MRI Blood-Pool Contrast Agent. |
| Q53503141 | Self-assembly of supramolecularly engineered polymers and their biomedical applications. |
| Q41875899 | Size-controlled and redox-responsive supramolecular nanoparticles |
| Q38638661 | Soft Supramolecular Nanoparticles by Noncovalent and Host-Guest Interactions |
| Q38556753 | Supramolecular hydrogels: synthesis, properties and their biomedical applications |
| Q37373702 | Supramolecular nanoparticles that target phosphoinositide-3-kinase overcome insulin resistance and exert pronounced antitumor efficacy |
| Q37206761 | The therapeutic efficacy of camptothecin-encapsulated supramolecular nanoparticles |
Search more.